Rectal cancer
Rectal cancer refers to cancer located between the dentate line and the junction of the sigmoid colon and rectum. It is one of the most common malignant tumors in the gastrointestinal tract. The main manifestations are dull abdominal pain and abdominal discomfort; when rectal cancer progresses to the late stage, there will be obvious lower abdominal pain. As the disease progresses and the tumor grows to a certain extent, the patient will experience systemic symptoms such as anemia and weight loss. Its incidence rate ranks third among malignant tumors in the world. In 2011, the incidence rate in my country was about 23/100,000, and the mortality rate was about 11/100,000, and it has been increasing year by year. However, the early colorectal symptoms are not obvious, and most patients are already in the late stage when diagnosed. The 5-year survival rate of such patients is less than 10%. More than 90% of the cases are over 40 years old. The incidence rate of colorectal cancer in men and women is similar worldwide, with men slightly higher than women.
Related Drugs
Oxaliplatin
Indication: Combined with 5-fluorouracil and folinic acid (leucovorin): first-line treatment of metastatic colorectal cancer; adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of the primary tumor. This indication is based on the results of foreign clinical studies.
Manufacturer:
Simcere Pharmaceutical Co., Ltd.
Capecitabine Tablets
Indication: FDA approved for the treatment of metastatic breast cancer that is resistant to conventional therapies and for the treatment of metastatic colorectal cancer in combination with Taxotere for the treatment of advanced breast cancer.
Capecitabine Tablets
Indication: FDA approved for the treatment of metastatic breast cancer that is resistant to conventional therapies and for the treatment of metastatic colorectal cancer in combination with Taxotere for the treatment of advanced breast cancer.
Capecitabine Tablets
Indication: FDA approved for the treatment of metastatic breast cancer that is resistant to conventional therapies and for the treatment of metastatic colorectal cancer in combination with Taxotere for the treatment of advanced breast cancer.
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:
Simcere Pharmaceutical Co., Ltd.
Calcium Folinate Capsules
Indication: 1. Used as an antidote for folic acid antagonists (such as methotrexate, pyrimethoprim or trimethoprim). 2. Used to prevent severe toxic effects caused by overdose or high-dose treatment with methotrexate. 3. Also used to treat megaloblastic anemia caused by folic acid deficiency. 4. Used in combination with 5-fluorouracil for advanced colon and rectal cancer.
Manufacturer:
Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd.
Oxaliplatin
Indication: Combined with 5-fluorouracil and folinic acid (leucovorin): first-line treatment of metastatic colorectal cancer; adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of the primary tumor. This indication is based on the results of foreign clinical studies.
Manufacturer:
Lianyungang JARI Pharmaceutical Co., Ltd.
Oxaliplatin
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:
Wuxi Taxus Pharmaceutical Co., Ltd.